VRC-AVIDNA036-00-VP

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRC-AVIDNA036-00-VP, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally [Phase 1]

See pricing